| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-714
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4415 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 |
| filingDate |
1996-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc1b6478473af8eb4311adb697648237
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90c72372ac50272432316bfad667bcbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5c784e8a5e1aedfdc394b0e3efbc53c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_079969501280466bd5080918bbee8546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_375f6c91f9adbbd5c3900b5c7b63c6e9 |
| publicationDate |
1998-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5798371-A |
| titleOfInvention |
Pharmaceutical composition endowed with an antialcoholic and nootropic effect |
| abstract |
PCT No. PCT/RU96/00006 Sec. 371 Date Sep. 6, 1996 Sec. 102(e) Date Sep. 6, 1996 PCT Filed Jan. 4, 1996 PCT Pub. No. WO96/21446 PCT Pub. Date Jul. 18, 1996A pharmaceutical composition having an antialcoholic and nootropic effect which is administered sublingually. The active ingredients of the composition are the amino acid L-threonine or a pharmaceutically acceptable salt thereof and vitamin B6. A method for reducing and eliminating the pathological attraction to alcohol and treatment of alcohol abstinence syndrome, as well as a method for increasing attention comprises sublingual administration of an effective amount of the composition. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011165262-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003153590-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006079811-A1 |
| priorityDate |
1995-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |